^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

OriC321

i
Associations
Company:
Zhejiang University
Drug class:
BCMA-targeted CAR-T immunotherapy, GPRC5D-targeted CAR-T immunotherapy
Related drugs:
Associations